OCT102

N/A

Report date: 2024/12/06 10:41:04

Base Information

Drug NameOCT102
Drug Alias NameOCT102OCT-102
ClassificationBiologics
Mechanisms of ActionCluster of differentiation 8 inhibitors
TargetsCluster of differentiation 8
Therapy Area/IndicationsDermatomyositis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOctagon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOctagon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDermatomyositis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A